MDCG Guidance on Qualification and Classification of Annex XVI Products: Classification Details
The new article describes in detail the applicable classification approach and highlights the key considerations associated thereto.
The new article describes in detail the applicable classification approach and highlights the key considerations associated thereto.
The new article highlights the aspects related to the timelines associated with the clinical investigations, the way they should be calculated, and other relevant matters.
The article highlights the key points associated with the regulatory framework for specific categories of medicinal products.
The article provides an overview of the provisions of a guidance document and highlights the key points to be taken into consideration by medical device manufacturers (software developers).
The article provides an overview of the approach to be applied when calculating regulatory fees associated with registration and authorization for medicines intended to be marketed and used in Ireland.
RegDesk is recognized as a Regulatory Intelligence Representative Vendor! Learn more by reading the 2024 Gartner® Market Guide for Regulatory Intelligence Solutions.
Get the report